volume 7, issue 12, P1212-1222 2015
DOI: 10.18632/aging.100867
View full text
Ian Guest, Zoran Ilic, Heidi Scrable, Stewart Sell

Abstract: Bone marrow transplantation is used to examine survival, hematopoietic stem cell function and pathology in recipients of young and old wild type bone marrow derived stem cells (BMDSCs) as well as cells from p53-based models of premature aging. There is no difference in the long term survival of recipients of 8 week-old p53+/m donor cells compared to recipients of 8 week-old wild-type (WT) donor cells (70 weeks) or of recipients of 16–18 weeks-old donor cells from either p53+/m or WT mice. There is shorter surv…

expand abstract